Spinal Stabilization Technologies Ltd.

Spinal Stabilization Technologies Ltd. is an international medical device company developing PerQdisc™, a lumbar intervertebral disc nucleus replacement system. The PerQdisc is an in-situ formed silicone-based prosthesis designed for patients undergoing nucleus replacement surgery to treat chronic discogenic low back pain associated with degenerative disc disease (DDD). The device is engineered to replace the diseased nucleus pulposus and emulate the natural biomechanical function of the native nucleus, enabling motion-preserving surgical intervention rather than fusion. The technology redistributes weight-bearing forces and mechanical properties of the intervertebral disc in a more physiological manner. Currently, the PerQdisc is classified as an investigational device limited to clinical trial use in the United States and is not approved for commercial sale in the US or CE-marked regions. The company is conducting the DISCPAIN1 clinical trial to establish safety and efficacy in patient populations suffering from degenerative disc disease with chronic low back pain.